Drug Target Review Antibodies ebook 2022

This ebook includes articles about antibody-based therapies that could protect against cancer by utilising a patient’s memory B cells. Also included is a piece on an intranasally-delivered monoclonal antibody treatment to potentially protect against SARS-CoV-2.

Looking at disease through a patient’s memory B cells can reveal vulnerabilities within pathogens. In this ebook, Dr Purnanand Sarma, President and Chief Executive Officer of Immunome, outlines how advancements in memory B-cell antibody-based treatments could aid in the development of cancer therapeutics.

While there have been many efforts to develop therapeutics that can protect against SARS-CoV-2 and treat patients following infection, the emergence of variants requires constant review of the options available. Also included in this ebook is a Q&A with Dr Chris Takimoto, Chief Medical Officer at IGM Biosciences, who explains how an intranasally-delivered monoclonal antibody could protect against SARS-CoV-2 infection and variants of concern.

In this ebook:

  • Viewing disease through the lens of memory B cells: improving cancer and infectious disease treatment
    Dr Purnanand Sarma, Immunome
  • Neutralising SARS-CoV-2 with intranasally-delivered antibodies
    Dr Chris Takimoto, IGM Biosciences